5Bonfiglio G, Laksai Y, Franchino L, et al. Mechanisms of beta - lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey. J Antimicrob Chemther, 1998, 42:697 ～ 702.
6Troillet N, Samore MH, Carmeli T, et al. Imipenem- resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin Infect Dis, 1997, 25:1094 ～ 1097.
3Ohya S,Fukuoka T,Masuda N,et al.Microbiological evaluation of panipenem/betamipron,a new parenterally active carlapenem V.increase in susceptibility of pseudomonas aeruginosa to panipenem in low.amino-acid media.Chemo Therapy,1991,39(S-3):132
4Levy SB.The Challenge of antibiotic resistance[J].Scientific American,1998,278:46-53
5Jones RN,Pfaller MA.Bacterial resistance: A worldwide problem[J].Diagn.Microbiol Infect Dis,1998,31:379-388
6Williams RJ,Ryan MJ.Surveillance of antimicrobial resistance-an international perspective[J].Br Med J,1998,317:651
7Am Society Microbiol.Report of the ASM task force on antibiotic resistance[J].Antimicrob Agents,Chemother,1995,Supplement: 1-23
8World Health Organization.WHO global strategy for containment of antimicrobial resistance.WHO/CDS/CSR/DRS/2001.2[J]
9Wang H,Huebner R,Chen M,et al.Antibiotic susceptibility patterns of Streptococcus pneumoniae in China and comparison of MICs by agar dilution and E test methods[J].Antimicrob Agents Chemother,1998,42:2633-2636
10Sahm DF,Karlowsky JA,Kelly LJ,et al.Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States:2-year longitudinal analysis[J].Antimicrob Agents Chemother,2001,45:1037-1042
